Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.39 Million CAD | -35.17% |
| 2022 | 20.66 Million CAD | -45.55% |
| 2021 | 37.95 Million CAD | -3.24% |
| 2020 | 39.22 Million CAD | -42.07% |
| 2019 | 67.71 Million CAD | -4.72% |
| 2018 | 71.07 Million CAD | 410.44% |
| 2017 | 13.92 Million CAD | 238.7% |
| 2016 | 4.11 Million CAD | 356.57% |
| 2015 | 900.42 Thousand CAD | 1277.44% |
| 2014 | 65.36 Thousand CAD | -91.28% |
| 2013 | 749.26 Thousand CAD | -26.49% |
| 2012 | 1.01 Million CAD | -33.97% |
| 2011 | 1.54 Million CAD | 25.31% |
| 2010 | 1.23 Million CAD | 70.92% |
| 2009 | 720.77 Thousand CAD | 824.08% |
| 2008 | 77.99 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 9.62 Million CAD | -27.2% |
| 2024 Q1 | 13.22 Million CAD | -1.29% |
| 2024 Q3 | 6.07 Million CAD | -36.94% |
| 2023 Q2 | 18.58 Million CAD | 6.16% |
| 2023 Q4 | 13.39 Million CAD | -21.38% |
| 2023 Q3 | 17.04 Million CAD | -8.31% |
| 2023 FY | 13.39 Million CAD | -35.17% |
| 2023 Q1 | 17.5 Million CAD | -15.29% |
| 2022 Q3 | 28.7 Million CAD | -7.35% |
| 2022 FY | 20.66 Million CAD | -45.55% |
| 2022 Q1 | 31.53 Million CAD | -16.92% |
| 2022 Q4 | 20.66 Million CAD | -27.98% |
| 2022 Q2 | 30.97 Million CAD | -1.77% |
| 2021 Q1 | 51.56 Million CAD | 31.45% |
| 2021 Q3 | 41.22 Million CAD | -11.12% |
| 2021 FY | 37.95 Million CAD | -3.24% |
| 2021 Q2 | 46.38 Million CAD | -10.05% |
| 2021 Q4 | 37.95 Million CAD | -7.92% |
| 2020 Q1 | 59.26 Million CAD | -12.48% |
| 2020 FY | 39.22 Million CAD | -42.07% |
| 2020 Q4 | 39.22 Million CAD | -15.6% |
| 2020 Q3 | 46.48 Million CAD | -11.24% |
| 2020 Q2 | 52.36 Million CAD | -11.64% |
| 2019 Q2 | 104.83 Million CAD | -5.28% |
| 2019 Q1 | 110.68 Million CAD | -5.39% |
| 2019 Q4 | 67.71 Million CAD | -28.01% |
| 2019 FY | 67.71 Million CAD | -4.72% |
| 2019 Q3 | 94.06 Million CAD | -10.27% |
| 2018 Q1 | 66.85 Million CAD | 220.55% |
| 2018 Q4 | 116.98 Million CAD | 64.6% |
| 2018 FY | 71.07 Million CAD | 410.44% |
| 2018 Q3 | 71.07 Million CAD | -8.83% |
| 2018 Q2 | 77.95 Million CAD | 16.6% |
| 2017 Q3 | 13.92 Million CAD | -34.85% |
| 2017 Q1 | 7.99 Million CAD | -9.86% |
| 2017 FY | 13.92 Million CAD | 238.7% |
| 2017 Q4 | 20.85 Million CAD | 49.79% |
| 2017 Q2 | 21.37 Million CAD | 167.47% |
| 2016 Q3 | 4.11 Million CAD | 202.89% |
| 2016 Q1 | 1.78 Million CAD | 6152.12% |
| 2016 Q4 | 8.86 Million CAD | 115.64% |
| 2016 Q2 | 1.35 Million CAD | -23.89% |
| 2016 FY | 4.11 Million CAD | 356.57% |
| 2015 Q2 | 36.71 Thousand CAD | -43.84% |
| 2015 Q1 | 65.36 Thousand CAD | -89.52% |
| 2015 FY | 900.42 Thousand CAD | 1277.44% |
| 2015 Q4 | 28.52 Thousand CAD | 77.76% |
| 2015 Q3 | 16.04 Thousand CAD | -56.29% |
| 2014 Q4 | 623.83 Thousand CAD | -13.74% |
| 2014 FY | 65.36 Thousand CAD | -91.28% |
| 2014 Q3 | 723.16 Thousand CAD | 3.45% |
| 2014 Q2 | 699.03 Thousand CAD | -6.7% |
| 2014 Q1 | 749.26 Thousand CAD | -6.11% |
| 2013 Q2 | 960.58 Thousand CAD | -5.76% |
| 2013 Q3 | 839.18 Thousand CAD | -12.64% |
| 2013 Q4 | 798 Thousand CAD | -4.91% |
| 2013 FY | 749.26 Thousand CAD | -26.49% |
| 2013 Q1 | 1.01 Million CAD | -4.99% |
| 2012 Q4 | 1.07 Million CAD | -8.05% |
| 2012 FY | 1.01 Million CAD | -33.97% |
| 2012 Q2 | 1.28 Million CAD | -16.45% |
| 2012 Q1 | 1.54 Million CAD | -52.35% |
| 2012 Q3 | 1.16 Million CAD | -9.54% |
| 2011 Q1 | 1.23 Million CAD | 14.7% |
| 2011 Q4 | 3.23 Million CAD | -4.68% |
| 2011 Q3 | 3.39 Million CAD | 29.79% |
| 2011 Q2 | 2.61 Million CAD | 112.54% |
| 2011 FY | 1.54 Million CAD | 25.31% |
| 2010 Q1 | 720.77 Thousand CAD | -6.25% |
| 2010 Q3 | 1.13 Million CAD | 110.06% |
| 2010 Q4 | 1.07 Million CAD | -5.06% |
| 2010 FY | 1.23 Million CAD | 70.92% |
| 2010 Q2 | 538.59 Thousand CAD | -25.28% |
| 2009 Q1 | 77.99 Thousand CAD | 0.0% |
| 2009 Q4 | 768.8 Thousand CAD | 0.0% |
| 2009 FY | 720.77 Thousand CAD | 824.08% |
| 2008 FY | 77.99 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 1.08 Million CAD | -1133.553% |
| CanadaBis Capital Inc. | 22.96 Million CAD | 41.649% |
| Decibel Cannabis Company Inc. | 142.98 Million CAD | 90.629% |
| Delivra Health Brands Inc. | 10.05 Million CAD | -33.298% |
| Entourage Health Corp. | 31.39 Million CAD | 57.318% |
| Cannara Biotech Inc. | 141.52 Million CAD | 90.532% |
| Medicure Inc. | 28.05 Million CAD | 52.247% |
| PharmaCielo Ltd. | 22.28 Million CAD | 39.886% |
| Rubicon Organics Inc. | 54.89 Million CAD | 75.59% |
| BioSyent Inc. | 41.52 Million CAD | 67.735% |
| Voyageur Pharmaceuticals Ltd. | 2.16 Million CAD | -519.28% |